Preview

Клиническая медицина

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Только для подписчиков

Свертываемость крови при коронавирусной инфекционной болезни: анализ проблемы и наше мнение

https://doi.org/10.30629/0023-2149-2020-98-6-405-413

Полный текст:

Аннотация

В статье дается обзор современной последней литературы, посвященной состоянию гемокоагуляции при вирусном заболевании COVID-19, которое вызывается SARS-CoV-2. Рассматриваются вопросы его патогенеза и высказываются предположения о возможной пользе больным от применения лекарственных препаратов, влияющих на тромбоцитарное звено свертывания крови.

Об авторах

И. Н. Бокарев
Всероссийская ассоциация по изучению тромбозов, геморрагий и патологии сосудов им. А.А. Шмидта–Б.А. Кудряшова
Россия
129327, Москва


Л. В. Попова
Всероссийская ассоциация по изучению тромбозов, геморрагий и патологии сосудов им. А.А. Шмидта–Б.А. Кудряшова; ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)
Россия

Попова Людмила Викторовна — кандидат медицинских наук, доцент кафедры госпитальной терапии №1 Института клинической медицины им. Н.В. Склифосовского

119991, Москва



Список литературы

1. worldometers.info [Электронный ресурс]. URL: https://www.worldometers.info/coronavirus/ (5 jule 2020).

2. Robb J.A., Bond C.W. Coronaviridae. Comprehensive Virology. 1979;6:193–247. DOI: 10.1007/978-1-4684-3563-4_3.

3. Communicable disease threats report, 9–15 February 2020, week 7. ECDC (5 jule 2020) [Электронный ресурс]. URL: https://www.ecdc.europa.eu/sites/default/files/documents/communicabledisease-threats-report-15-Feb-2020-PUBLIC.pdf.

4. International Committee on Taxonomy of Viruses ICTV [Электронный ресурс]. URL: https://talk.ictvonline.org/ (5 june 2020).

5. Beeching N.J., Fletcher T.E., Fowler R. COVID-19. BMJ Best Practices. BMJ Publishing Group (17 февраля 2020).

6. Министерство здравоохранения Российской Федерации [Электронный ресурс]. URL: https://minzdrav.gov.ru.(5 jule 2020)

7. Dijkman R., Jebbink M.F., Deijs M, Milewska A., Pyrc K, Buelow E. et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J. Gen. Virol. 2012;93(9):1924–1929. DOI: 10.1099/vir.0.043919-0.

8. Li W., Moore M.J., Vasilieva N., Sui J., Wong S. K., Berne M. A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. DOI: 10.1038/nature02145.

9. Robb J. What I am doing for the upcoming COVID-19 (coronavirus) pandemic [Электронный ресурс]. http://www.europe-solidaire.org/spip.php?article52289 (5 jule 2020)

10. Carsana L., Sonzogni A., Nasr A., Rossi R.S., Pellegrinelli A., Zerbi P. et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study Lancet. 2020. [Epub ahead of print]. DOI: 10.1016/S14733099(20)30434-5.

11. Зайратьянц О.В., Самсонова М.В., Михалева Л.М., Черняев А.Л., Мишнев О.Д., Крупнов Н.М., Калинин Д.В. Патологическая анатомия COVID-19. Атлас. Москва 2020. С 140.

12. BTS Guidance on Venous Thromboembolic Disease in patients with COVID-19. Updated 4 May 2020. British Thoracic Society [Электронный ресурс]. URL: https://brit-thoracic.org.uk/documentlibrary/quality-improvement/covid-19/bts-guidance-on-venousthromboembolic-disease-inpatients-with-covid-19/. (5 jule 2020)

13. Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemos. 2020;18(6):1421–1424. DOI: 10.1111/jth.14830

14. Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145–147. DOI: 10.1016/j.thromres.2020.04.013.

15. Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Müller M.C.A. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1995– 2002. DOI: 10.1111/jth.14888.

16. Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X. et al. High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. DOI: 10.1007/s0013402006062-x.

17. Grillet F., Behr J., Calame P., Aubry S., Delabrousse E. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography. Radiology. 2020. [Epub ahead of print] DOI: 10.1148/radiol.2020201544

18. Bompard F., Monnier H., Saab I., Tordjman M., Abdoul H., Fournier L. et al. Pulmonary embolism in patients with Covid-19 pneumonia. Revel. Eur. Respir. J. 2020. [Epub ahead of print]. DOI: 10.1183/13993003.01365-2020.

19. Poyiadji N., Cormier P., Patel P.Y., Hadied M.O., Bhargava P., Khanna K. et al. Acute Pulmonary Embolism and COVID-19. Radiol. 2020. [Epub ahead of print]. DOI: 10.1148/radiol.2020201955.Radiology.

20. Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T. et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. DOI: 10.1016/j.thromres.2020.04.024.

21. Wichmann D., Sperhake J.P., Lutgehetmann M., Steurer S., Edler C., Heinemann A. et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann. Intern. Med. 2020;M20– 2003. [Epub ahead of print]. DOI: 10.7326/M20-200320-2003.

22. Lax S.F., Skok K., Zechner P., Kessler H.H., Kaufmann N., Koelblinger C., et al Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann. Intern. Med. 2020;14:20–2566. [Epub ahead of print]. DOI: 10.7326/M20-2566.

23. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE. 2018. [Электронный ресурс]. URL: https://www.nice.org.uk/guidance/ng89 (10 may 2020).

24. Cook D., Crowther M., Meade M., Rabbat C., Griffith L., Schiff D. et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit. Care Med. 2005; 33(7):1565–1571. DOI: 10.1097/01.CCM.0000171207.95319.B2.

25. Hunt B.J. Preventing Venous Thromboembolism in the Critically Ill — Can We do More? J. Intensive Care Soc. 2014;5(3):3–5. DOI: 10.1177/17511437140151S302.

26. Zhang Ch., Zhang Z., Mi J., Wang X., Zou Y., Chen X. et al. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis. Medicine (Baltimore). 2019;98(23):e15833. DOI: 10.1097/MD.0000000000015833.

27. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(04):844–847. DOI: 10.1111/jth.14768.

28. Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V. et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. J. Thromb. Haemost. 2020;18(7):1738–1742. DOI: 10.1111/jth.14850.

29. Azouz E., Yang S., Monnier-Cholley L., Arrivé L. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19. Intensive Care Med. 2020;46:1464–1465. DOI: 10.1007/s00134-020-06079-2.

30. Bellosta R., Luzzani L., Natalini G., Bellosta R., Luzzani L., Natalini G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;S0741–5214(20)31080-6. DOI: 10.1016/j.jvs.2020.04.483.

31. Ueki Y., Otsuka T., Windecker S., Räber L. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. Eur. Heart. J. 2020;41(22):2134. DOI: 10.1093/eurheartj/ehaa399ehaa399.

32. Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes Circulation. Circulation. 2020;141(25):2113–2116. DOI: 10.1161/CIRCULATIONAHA.120.047525.

33. Yaghi S, Ishida K, Torres J, Grory B.M., Raz E., Humbert K. et al. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. Originally published 20 May 2020 [Epub ahead of print]. DOI: 10.1161/STROKEAHA.120.030335.

34. Kwaan H.C. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae. Seminars in thrombosis and hemostasis. [Epub ahead of print]. DOI: 10.1055/s-0040-1709996.

35. Brown N.J, Kim K.S, Chen Y.Q., Blevins L.S., Nadeau J.H., Meranze S.G., Vaughan D.E. et al. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J. Clin. Endocrinol. Metab. 2000;85(01):336–344. DOI: 10.1210/jcem.85.1.6305.

36. Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A, Solomon S.D. et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N. Engl. J. Med. 2020;382:1653– 1659. DOI: 10.1056/NEJMsr2005760.

37. Zhou F., Yu T., Du R., Ting Yu., Du R., Fan G., Ying Liu, Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/S01406736(20)30566-3.

38. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S01406736(20)30183-5.

39. Harzallah I., Debliquis A., Drenou B. Lupus anticoagulant is frequent in patients with Covid-19. J. Thromb. Haemost. 2020. [Epub ahead of print]. DOI: 10.1111/jth.14867.

40. Tichelaar V., Mulder A., Kluin-Nelemans H., Meijer K. The acute phase reaction explains only a part of initially elevated factor VIII: C levels: a prospective cohort study bin patient with venous thrombosis. Thromb. Res. 2012;129:183–186. DOI: 10.1016/j.thromres.2011.09.024.

41. Hantgan R.R., Simpson-Haidaris P.J., Francis C.W., Marder V.J. Fibrinogen structure and physiology. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed. by R.W. Colman, Hirsh, V.J. Marder, A.W. Clowes & J.N. George), Lippincott Williams and Wilkins, Philadelphia, PA 2001:203–232.

42. Taylor F.B., Toh C.H. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascularcoagulation. Thromb. Haemost. 2001;86:1327–1330.

43. Kumar A., Arora A., Sharma P., Anikhindi S.A., Bansal N., Singla V. et al. Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. MedRx-iv. 2020. [Epub ahead of print]. DOI: 10.2139/ssrn.3566166.

44. Ma C., Gu J., Hou P., Ma C., Gu J., Hou P. et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020. [Epub ahead of print]. DOI: 10.1101/2020.03.17.20037572.

45. Sadosty A.T, Goyal D.G., Boie E.T., Chiu C.K. Emergency department D-dimer testing. J. Emergency Med. 2001;21(4):423–429.

46. Yin S., Huang M., Li D., Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARSCoV-2. J. Thromb. Thrombolysis. 2020 Apr;3:1–4. [Epub ahead of print]. DOI: 10.1007/s11239-020-02105-8.

47. Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G-J., Harjola V-P. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2020;41(4):543–603. DOI: doi.org/10.1093/eurheartj/ehz405

48. Stoneham S.M., Milne K.M., Nuttal E., Frew G.H, Sturrock B., Sivaloganathan H. et al. Thrombotic risk in COVID-19: a case series and case–control study. Clin. Med. 2020. [Epub ahead of print]. DOI: https://doi.org/10.7861/clinmed.2020-0228.

49. Yang X., Yang Q., Wang Y., Wu Y., Xu J., Yu Y. et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J. Thromb. Haemost. 2020;18(6):1469–1472. [Epub ahead of print]. DOI: 10.1111/jth.14848.

50. Lippi G., Plebani M., Henry M.B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta. 2020;506:145–148. DOI: 10.1016/j.cca.2020.03.022.

51. Tang N, Bai H, Chen X, Gong J., Li D., Sun Z. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18(05):1094–1099. DOI: 10.1111/jth.14817.

52. Yang X., Shang Y. Response to «What do monitoring platelet counts in COVID-19 teach us?». J. Thromb. Haemost. 2020;18(8):2073. Online ahead of print. DOI: 10.1111/jth.14889.

53. Manne BK, Xiang SC, Rondina MT. Platelet secretion in inflammatory and infectious diseases. Platelets. 2017;28(2):155–164. DOI: 10.1080/09537104.2016.1240766

54. Stockschlaeder M., Schneppenheim R., Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul. Fibrinolysis. 2014;25(03):206–216. DOI: 10.1097/MBC.0000000000000065.

55. Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C., Martin-Loeches I., Browne P. et al. COVID-19 Coagulopathy in Caucasian patients. Brit. J. Haematol. 2020;189:1044–1049. DOI: /10.1111/bjh.16749.

56. Joob B., Wantwit V. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients. Clinical and Applied Thrombosis/Hemostasis. 2020Jan-Dec;26. [Epub ahead of print]. DOI: 10.1177/1076029620918308.

57. Мачабели М.С. Тромбогеморрагический синдром. Пробл. гематол. 1981;1:48–54.

58. Sharifi-Razavi A., Karimi N., Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. [Epub ahead of print]. DOI: 10.1016/j.nmni.2020.100669.

59. Xiao F, Tang M, Zheng X, Liu Y., Li X., Shan H. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(06):1831.e3–1833.e3. [Epub ahead of print]. DOI: 10.1053/j.gastro.2020.02.055.

60. Iba T., Nisio M.D., Levy J.H., et al. New criteria for sepsis — induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7:e017046. DOI: 10.1136/bmjopen-2017-017046.

61. Iba T., Levy J.H., Yamakawa K., Kitamura N., Thachil J. Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J. Thromb. Haemost. 2019;17(8):1265–1268. DOI: 10.1111/jth.14578.

62. Bokarev I.N., Popova L.V. Detection of disseminated intravascular coagulation with the help of the conception of constant intravascular microcoagulation. Srp. Arh. Celok. Lek. 2010;138(1):53–58. DOI: 10,2298/sarh10s1053b.

63. Бокарев И.Н., Попова Л.В., Савин А.А. ДВС-синдром и постоянное внутрисосудистое микросвертывание крови. Москва .2016.

64. Бокарев И.Н, Щепотин Б.М.,. Ена Я.М. Внутрисосудистое свертывание крови Киев : Здоровья, 1989. С. 237

65. Великов В.К. Хроническое внутрисосудистое микросвертывание крови и диабетическая микроангиопатия. Терапевтический архив. 1989;5:26.

66. Marietta M., Ageno W., Artoni A., De Candia E., Gresele P., Marchetti M., et al. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020;18(03):167–169. DOI: 10.2450/2020.0083-20.

67. Oudkerk M., Buller H.R., Kuijpers D., van Es N., Oudkerk S.F., McLoud T.C., et al. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology. 2020:201629. DOI: 10.1148/radiol.2020201629.

68. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). 2020; Версия 6 (28.04.2020).

69. Spyropoulos A.C., Levy J.H., Ageno W., Connors J.M., Hunt B.J., Iba T. et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1859–1865. DOI: 10.1111/jth.14929. doi: 10.1111/jth.14929

70. Moores L.K., Tritschler T., i Brosnahan S., Carrier M., Collen J.F., Doerschug K., et al. Prevention, Diagnosis and Treatment of VTE in Patients With COVID-19 CHEST Guideline and Expert Panel Report Chest. 2020. [Epub ahead of print] DOI: 10.1016/j.chest.2020.05.559.


Для цитирования:


Бокарев И.Н., Попова Л.В. Свертываемость крови при коронавирусной инфекционной болезни: анализ проблемы и наше мнение. Клиническая медицина. 2020;98(6):405-413. https://doi.org/10.30629/0023-2149-2020-98-6-405-413

For citation:


Bokarev I.N., Popova L.V. Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion. Clinical Medicine (Russian Journal). 2020;98(6):405-413. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-6-405-413

Просмотров: 175


ISSN 0023-2149 (Print)
ISSN 2412-1339 (Online)